Friday, November 15, 2024
- Advertisement -spot_img

TAG

Wockhardt antibiotic

Wockhardt’s new antibiotic WCK 6777 gains FDA fast track status, completes phase I trial, stocks decline 

Wockhardt Limited announced today that its novel antibiotic WCK 6777 (Ertapenem/Zidebactam) has been granted Fast Track designation by the USFDA for treating complicated...

Latest news

- Advertisement -spot_img